Company Filing History:
Years Active: 2022-2025
Title: Jiawang Guo: Innovator in Pharmaceutical Development
Introduction
Jiawang Guo is a notable inventor based in Taicang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of receptor agonists. His work has led to the filing of multiple patents, showcasing his innovative approach to drug formulation.
Latest Patents
Jiawang Guo holds 2 patents related to the addition salt of S1P1 receptor agonists and their crystal forms. His latest patents include a detailed disclosure of a salt form and a crystal form of a drug designed to treat S1P1 receptor mediated diseases. The drug, identified as 1-{2-fluoro-4-[5-(4-isobutylphenyl)-1,2,4-oxadiazole-3-yl]benzyl}-3-azetidinecarboxylic acid, is aimed at providing therapeutic benefits for various symptoms associated with these diseases. The patents also outline preparation methods for these forms and their use in pharmaceutical compositions.
Career Highlights
Jiawang Guo is currently associated with Suzhou Connect Biopharmaceuticals, Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation in drug development, particularly in the area of receptor-mediated therapies.
Collaborations
Jiawang collaborates with esteemed colleagues such as Wei Zheng and Wubin Pan, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jiawang Guo's contributions to pharmaceutical science through his patents and collaborative efforts highlight his role as a key innovator in the field. His work not only advances medical science but also offers potential solutions for treating complex diseases.